Abstract
Purpose
It is widely accepted that National Cancer Control Plans (NCCPs) are essential to improve cancer care. They often describe the structural requirements such as cancer centers, clinical cancer registries and quality control. During the 2nd European roundtable meeting, the implementation processes were analyzed and discussed.
Results
Communication strategies between cancer registries and cancer centers need to be developed. Analyses and discussion of collected data have to be performed by multidisciplinary teams. This has to be followed by appropriate actions to improve quality of care. It is essential to describe the clinical procedures, organizational processes and communication between individuals and professional teams. The patients’ perspectives have to be included in the development of cancer care networks. The patients’ feedback on cancer care is a routine quality indicator.
Conclusion
NCCPs that include the description of structural requirements are important. In addition, it is essential to develop cancer care networks including multidisciplinary organizational processes to guarantee high quality. These have to consider patients preferences.
Similar content being viewed by others
References
Coebergh JW, van den Hurk C, Louwmann M, Comber H, Rosso S, Zanetti R, Sacchetto L, Storm H, van Veen EB, Siesling S, van den Eijinden-van Raaij J (2015) EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees in Europe: from roots to fruits. Eur J Cancer 51:1050–1063
Martin Moreno JM, Albrecht T, Rados Kruel S (eds) (2013) Boosting Innovation and cooperation in European Cancer Control: key findings from the European Partnership for Action Against Cancer (EPAAC) National Institution of Public Health of the Republic of Slovenia and World Health Organization
Ortmann O, Helbig K, Torode J (2015) Improving cancer care in Europe: which institutional health structures might be beneficial and why? 1. European Roundtable Meeting (ERTM), 16th May 2014, Berlin, Germany. J Cancer Res Clin Oncol. doi:10.1007/s00432-014-1906-x
Author’s contribution
O. Ortmann, J. Torode, and U. Helbig wrote and edited the manuscripts.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
The participants of the ERTM are listed in the “Appendix”.
Appendix: List of all participants
Appendix: List of all participants
-
Prof. Tit Albreht, Head of the Center for Health Care, National Institute of Public Health, Slovenia.
-
Prof. Dr. Jorge Borras, Scientific Coordinator Spanish Cancer Strategy/EPAAC, Director Hospital Duran i Reynals, Spain.
-
Dr. Johannes Bruns, Secretary-General, German Cancer Society, Germany.
-
Prof. Dr. Jan-Willem Coebergh, Department of Public Health, Erasmus MC Rotterdam, The Netherlands.
-
Dr. Silvia Deandrea, European Commission Joint Research Centre, Institute for Health and Consumer Protection—Ispra (Varese), Italy.
-
Dr. Markus Follmann, Head of the Division of Guidelines/EbM, German Cancer Society; German Guideline Program in Oncology (GGPO), Germany.
-
Dr. Ulrike Helbig, General Manager of the Section A, International Coordination, German Cancer Society, Germany (Rapporteur).
-
Prof. Dr. Dieter Hölzel, former Director, Tumor Registry Munich, Germany.
-
Isabelle Ladiges, Policy Officer, European Commission, Directorate-General for Health and Consumers Unit C1-Programme Management and Diseases, Luxemburg.
-
Prof. Dr. Florian Lordick, Board Member and Secretary, German Cancer Society, Director University Cancer Center Leipzig, Germany.
-
Dr. Katrin Mugele, Organisational Communication Specialist, German Cancer Society, Germany.
-
Prof. Dr. Olaf Ortmann, Board member and Speaker of the Section B, German Cancer Society, Chairman of the Department of Obstetrics and Gynecology, University of Regensburg, Germany.
-
Charles Revkin, Communications and Marketing Specialist, Union for International Cancer Control (UICC), Switzerland (Rapporteur).
-
Prof. Dr. Ulrik Ringborg, Director Cancer Center Karolinska, Sweden.
-
Dr. Simone Wesselmann, Head of the Certification Department, German Cancer Society, Germany.
-
Dr. Wendy Yared, CEO European Cancer League, Brussels, European Union.
Rights and permissions
About this article
Cite this article
Ortmann, O., Torode, J. & Helbig, U. Improving structural development in oncology: transformation of theoretical health care standards and knowledge into a practical approach—2nd European Roundtable Meeting (ERTM), May 8, 2015, Berlin, Germany. J Cancer Res Clin Oncol 142, 807–811 (2016). https://doi.org/10.1007/s00432-015-2052-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-015-2052-9